Germline mutations in lung cancer

Publication date: Available online 11 January 2019Source: Respiratory InvestigationAuthor(s): Takehito Shukuya, Kazuhisa TakahashiAbstractGenetic testing for alterations in oncogenic driver genes has become essential and standard in the clinical practice of the treatment of lung cancer. Germline mutations potentially predisposing patients to lung cancer are rare; however, with the introduction of next-generation sequencing in the clinical practice of lung cancer, the identification of potentially predisposing germline abnormalities is becoming more common. In addition, liquid biopsy, which analyzes cell-free DNA in blood, increases the possibility of detecting these germline mutations. In this review, we summarize the germline mutations detected in lung cancer patients and briefly describe the future perspectives.
Source: Respiratory Investigation - Category: Respiratory Medicine Source Type: research